Skip to Main Content

If the U.S. wants a better deal on some medicines, the federal government could try pegging prices to what is paid by Japan, the U.K., and the Canadian province of Ontario.

Why? A new study finds that prices paid for 79 different brand-name prescription drugs averaged 3.2 to 4.1 times higher in the U.S. and that if Medicare Part D had used the same pricing as in those other locations, the federal health care program could have saved nearly $73 billion last year. The analysis also found that the longer a drug was on the market, the larger the difference in pricing grew.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED